Patent News: Breaking Patent News, Comments and Articles.

TROY Awarded Patent for TROY Copy Evident Pantograph: Security Feature Included in TROY Secure Print Enterprise Creates Secure Printed Prescriptions

TROY healthcare solutions employ advanced imaging technologies to offer secure printing solutions for medical providers. Costa Mesa, CA (PRWEB) June 19, 2013 TROY Group, Inc., a worldwide leader in the printing and management of security documents, has developed an advanced imaging technology that deters unauthorized copying. TROY was recently assigned a U.S. patent (8,405,882) for TROY Copy Evid...

Manches' Patent Expertise Recognised at an International Level (News)

04 June 2013: Oxford, UK - Manches LLP Thames Valley is delighted to announce that intellectual property partner, Chris Shelley, has been recognised as one of the World's Leading Patent Practitioners ...

Invivoscribe FLT3 Testing Patents Strengthened by Supreme Court Ruling

SAN DIEGO, CA -- (Marketwired) -- 06/19/13 -- In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the diagnostic community to note that the limits of the Myriad decision applies only to patents on genes and portions of genes themselves, 'compositions of matter' that already exist in nature. In contrast, Invivo...

Prana Presents New Benchmark Test to Assess Huntington's Disease Patients in Clinical Trials

MELBOURNE, AUSTRALIA -- (Marketwired) -- 06/19/13 -- Melbourne-based Prana Biotechnology (ASX: PBT) (NASDAQ: PRAN) has unveiled a world first, patient-reported outcomes study for Huntington's Disease (HD) in a poster presentation at the 17th Annual Congress of Parkinson's Disease and Movement Disorders being held in Sydney this week. The Poster entitled: "The Huntington's Disease patient-reporte...

Genetic Technologies Executes Agreement With Further Nationwide Provider Network for BREVAGen(TM)

MELBOURNE, AUSTRALIA -- (Marketwired) -- 06/19/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that through its wholly-owned subsidiary Phenogen Sciences Inc. it has executed an agreement with FedMed Inc. of Rockville, Maryland to use the FedMed national provider network. FedMed Inc. is a national provider network that includes more than 550,000 physicians, 60...

Sunshine Biopharma's Anticancer Drug Candidate, Adva-27a, Is Unaffected by the Recent Supreme Court Ruling on Patentability of Human Genes

MONTREAL -- (Marketwired) -- 06/19/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announces that its operations are unaffected by the recent Supreme Court ruling on patentability of Human Genes. Sunshine Biopharma's anticancer drug development program is n...

Apama Medical receives patent for low profile electrodes in US

The US Patent and Trademark Office (USPTO) has granted a patent to Apama Medical for its Low Profile Electrodes.

NDRC Releases Drug Pricing Reform Roadmap: From Price Caps To Prices

China’s National Development and Reform Commission has issued a roadmap for medical and pharma pricing reforms, covering patent-off drugs, generics and medical devices which proposes allowing market-determined pricing where appropriate.

U.S. court finds Novo Nordisk Prandin diabetes drug patent invalid

(Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction of a generic version of the medicine, the Danish drugmaker said on Tuesday.

US court finds Novo Nordisk Prandin diabetes drug patent invalid

June 18 (Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction of a generic version of the medicine, the Danish drugmaker said on Tuesday....

Put Myriad vs AMP to Bed

I've been away awhile and haven't been posting as regularly as in the past. Hence, I wasn't writing on the day the Supreme court issued its ruling in the AMP vs Myriad. Of course, by now you know they said that "a naturally occuring DNA segment is a...

SpineGuard Receives U.S. Patent for PediGuard® Pedicle Screw

SpineGuard (FR0011464452 – ALSGD), announced today that it has been issued a U.S. patent for the integration of its PediGuard sensor technology directly onto the tip of a pedicle screw. In SpineGuard’s ‘smart screw’ concept, the sensor of the PediGuard technology is embedded in the implantable pedicle screw itself, and the electronic is lo...

Myriad, Finally: Supreme Court Surprises by not Surprising

After what seemed like an eternity, the epic saga known as AMP v. Myriad Genetics has finally come to a close. On June 13, 2013, the Supreme Court ruled (1) that isolated genomic DNA (gDNA) is not patent-eligible under section 101 of the Patent Act,...

US Pay-For-Delay Deals Can be Challenged but are Not Illegal

Précis:  Deals by pharmaceutical companies to delay generic competition can be challenged by US regulators but are not in themselves illegal, according to a recent ruling by the Supreme Court....

Decoding Annie Parker-A movie about the discovery of the BRCA1 gene

I currently teach two online versions of a genomics course as a faculty lecturer at UIUC (one for undergraduates and one for certified teachers working on their Masters of Science Teaching Biology), and I love it when a topic I am teaching hits the n...

FORMA Therapeutics Launches New Collaborative Framework to Transform Basic Research into Promising Therapies

ADDCos uniquely integrate FORMA’s drug discovery engine with academic-based innovators for patient benefit FORMA Therapeutics announced today its Asset Discovery and Development Company (“ADDCo”) platform, an initiative in which FORMA will join forces with select academic, not-for-profit and venture philanthropy institutions to transform basic re...

Is Patenting Genes Fair to Society?

A company identified the relationship between a certain gene and increased breast cancer risk. They patented that association. Bioethicist Art Caplan asks, why not patent the moon and the stars? Medscape Business of Medicine

Imprimis Pharmaceuticals acquires Buderer intellectual property assets

Imprimis Pharmaceuticals has acquired the intellectual property (IP) rights related to proprietary innovations from the compounding pharmacy operations of Ohio-based Buderer Drug, a compounding pharmacy member of PCCA.

Professor Moshe Shoham Awarded 2013 Thomas A. Edison Patent Award

Inventor of Renaissance™ System Honored Mazor Robotics Ltd. (TASE: MZOR; NASDAQCM: MZOR), a developer of innovative surgical robots and complementary products, today announced that Professor Moshe Shoham was awarded the Thomas A. Edison Patent Award from the American Society of Mechanical Engineers (ASME). Professor Shoham was recognized for his inve...

US Supreme Court says patent settlement can "sometimes" be illegal

In a long awaited ruling in the USA, the US Supreme Court yesterday (June 17) ruled in the patent settlement litigation - or "pay-for-delay" case, in the case of Federal Trade Commission v Actavis Inc, voting by five to three that the FTC has the rig...

SCOTUS: Antitrust applies in pay-for-delay, but gotta prove it

The decision ultimately is a big gain for the FTC, which has insisted the patent settlement deals in which innovator drug makers pay their generic competitors to stay out of the market for a certain period has cost US consumers $3.5 billion per year,...

Actelion Braces For Tracleer Patent Cliff With New Drugs, New Data Standards

Actelion is preparing for the patent loss on its leading PAH drug not simply with a new product, but by setting a new efficacy standard across the entire PAH community.

Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons

CAMPBELL, Calif., June 18, 2013 /PRNewswire/ -- Apama Medical, a privately held medical device company focused on the development of next-generation atrial fibrillation technologies, today announced the issuance of U.S. Patent No. 8295902 by the US Patent and Trademark Office (USPTO), titled "Low Profile Electrodes". The patent encompasses low profile electrode assemblies for use on expandable str...

Professor Moshe Shoham recognized with Thomas A. Edison Patent Award

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced that Professor Moshe Shoham was awarded the Thomas A. Edison Patent Award from the American Society of Mechanical Engineers.

Supreme Court Says Government Can Challenge 'Pay For Delay' Generic Drug Deals

redOrbit Staff & Wire Reports - Your Universe Online Profit-sharing arrangements between generic and brand name drug companies that preserve patents and prevent competition are not inherently legal, and can be challenged as anti-competitive, the US Supreme Court ruled on Monday. These “pay for delay” deals arise when a generic drug company settles with a brand name drug maker over a ques...